PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment.
Godfroid C, Romero J, Labiano S, Chuang CH, Kelemen A, Wyss T, Roh V, Verdeil G, Klein C, Codarri Deak L, Umaña P, Tolstonog GV, Trumpfheller C, Vozenin MC, Romero PJ.
Godfroid C, et al. Among authors: vozenin mc.
J Immunother Cancer. 2025 Jan 22;13(1):e009832. doi: 10.1136/jitc-2024-009832.
J Immunother Cancer. 2025.
PMID: 39848686